Literature DB >> 25023188

The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease.

Nicolás Velasco1, Alvaro Contreras, Bruno Grassi.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to present the pathophysiological mechanisms and most recent clinical evidence regarding the role of the Mediterranean diet in preventing and treating nonalcoholic fatty liver disease (NAFLD). RECENT
FINDINGS: Several components of the Mediterranean diet have proven benefits in controlling the pathophysiological mechanisms involved in NAFLD. However, the few clinical studies that have assessed the diet have involved low numbers of patients and lacked methodological rigor. The results of these studies suggest that the Mediterranean diet attenuates the progression of NAFLD once it is established, but does not contribute to preventing the disease in patients at risk.
SUMMARY: Although there is a lack of clinical evidence derived from studies with high-quality methodology, the pathophysiological mechanisms of NAFLD shared with other associated pathologies suggest that there is a role for the Mediterranean diet in managing NAFLD. Studies with better methodology are needed to confirm the impact of the diet.

Entities:  

Mesh:

Year:  2014        PMID: 25023188     DOI: 10.1097/MCO.0000000000000071

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  4 in total

1.  High dietary intake of palm oils compromises glucose tolerance whereas high dietary intake of olive oil compromises liver lipid metabolism and integrity.

Authors:  Youzan Ferdinand Djohan; Eric Badia; Beatrice Bonafos; Gilles Fouret; Céline Lauret; Anne-Marie Dupuy; Edith Pinot; Thibault Sutra; Sylvie Gaillet; Karen Lambert; Fabrice Raynaud; Nathalie Gayrard; Bernard Jover; Absalome Aké Monde; Jean Paul Cristol; Charles Coudray; Christine Feillet-Coudray
Journal:  Eur J Nutr       Date:  2018-11-03       Impact factor: 5.614

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

3.  Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.

Authors:  Jiantao Ma; Rachel Hennein; Chunyu Liu; Michelle T Long; Udo Hoffmann; Paul F Jacques; Alice H Lichtenstein; Frank B Hu; Daniel Levy
Journal:  Gastroenterology       Date:  2018-03-29       Impact factor: 22.682

Review 4.  Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.

Authors:  Claudia P Oliveira; Priscila de Lima Sanches; Erlon Oliveira de Abreu-Silva; Aline Marcadenti
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.